article thumbnail

Will Cava Going Public Set the Table for Other IPOs?

Successful Acquisitions

Will Cava Going Public Set the Table for Other IPOs? By David Braun, Founder and CEO, Capstone Strategic When Washington DC based restaurant chain Cava became a publicly traded company recently, it bucked a trend that has lasted nearly two years, a notable absence of American IPOs.

IPO 111
article thumbnail

Drinks With The Deal: SPAC Sponsor Sloan Talks DraftKings

The Deal

Sloan’s first career was in entertainment, as he was the chairman of Metro-Goldwyn-Mayer Studios Inc., Sloan still sits on the board of Lions Gate Entertainment Corp. And while Sloan said he believes deeply in SPACs serving a purpose in bringing companies public, he revealed that for most companies, a traditional IPO is a better fit.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

“Dumb Money” Review: A Worthy Addition to the Classic Finance Movie Roster?

Mergers and Inquisitions

There are some entertaining moments and good performances, so I wouldn’t call the movie “bad.” Everyone was locked up inside, and many turned to day trading for entertainment and money (in between binge-watching shows on streaming services). I wrote many articles about it. Remember when Chamath was on CNBC all the time ?

Finance 96
article thumbnail

Sports Private Equity: Bright Spot in a Troubled PE Landscape or an Emerging Bubble?

Mergers and Inquisitions

Others with a broader “entertainment” focus include Atairos, Causeway, The Chernin Group, Elysian Park (more of a VC), Fiume Capital, and Zelnick Media. Larger, Diversified Funds That Also Invest in Sports As sports investing became more popular, many firms with a traditional TMT or media/entertainment focus also got involved.

article thumbnail

Go1 snaps up speed reading app Blinkist to expand in enterprise learning

TechCrunch: M&A

Content needs to be engaging and entertaining and you need to be recommended the right thing at the right time to keep you going. Barnes said that an IPO was part of the long-term plan but that “it’s not something we are targeting right now.” .” But there is still something missing in those takes, he continued.

article thumbnail

Cooley’s 2023 Tech M&A Year in Review: An AI-Generated Glass Half Full

Cooley M&A

Private equity slowed but not stopped by financing environment Despite record amounts of dry powder accumulating for sponsors, high financing costs, persistent valuation gaps and a closed tech IPO market led to a significant decrease in private equity M&A activity in 2023. Despite some isolated bright spots – such as Thoma Bravo’s $10.7

M&A 59
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.

M&A 40